iSpecimen Inc. (ISPC) News
Filter ISPC News Items
ISPC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ISPC News Highlights
- ISPC's 30 day story count now stands at 2.
- Over the past 14 days, the trend for ISPC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about ISPC are MD.
Latest ISPC News From Around the Web
Below are the latest news stories about iSpecimen Inc that investors may wish to consider to help them evaluate ISPC as an investment opportunity.
iSpecimen to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13-15, 2021iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually on September 13-15, 2021. Dr. Ianelli's corporate presentation will be available on-demand starting Monday, September 13, 2021 at 7:00 a.m. ET. |
iSpecimen Expands Human Biospecimen Offerings for Cancer ResearchersiSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced it has grown its cancer-related supplier network despite lockdowns, slowdowns, and sustained concern around the COVID-19 pandemic. |
iSpecimen Inc. Interview to Air on the RedChip Money Report® on Bloomberg TViSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that an interview with its CEO and President, Dr. Christopher Ianelli, will air on The RedChip Money Report® on Bloomberg TV, at 7 p.m. Eastern Time (ET) on August 14, 2021. Bloomberg TV is available in an estimated 73 million homes across the United States. |
iSpecimen Reports Second Quarter 2021 Financial ResultsiSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today reported its financial results for the three-month period ended June 30, 2021. |
iSpecimen Launches Enhanced Custom Collection ServiceiSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that it has enhanced its custom biofluids collection service to offer life sciences organizations faster delivery of urgently needed research samples. |
iSpecimen to Report Second Quarter 2021 Results on August 10, 2021iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it will report its financial results for the second quarter ended June 30, 2021, before the market open on Tuesday, August 10, 2021. |
iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public OfferingiSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of the issuance of an additional 337,500 shares of its common stock pursuant to the full exercise of the underwriters' over-allotment option in connection with the Company's initial public offering (the "IPO"). The additional shares were sold at the initial offering price of $8.00 per share, resulting in additional gross proceeds of $2,700,000 and bringing the t |
iSpecimen Announces Closing of Initial Public OfferingiSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of its previously announced initial public offering of 2,250,000 shares of its common stock at a price of $8.00 per share, for gross proceeds of $18,000,000 before deducting underwriting discounts, commissions and offering expenses. The shares of common stock began trading on the Nasdaq Capital Market under the ticker symbol "ISPC" on June 17, 2021. |
iSpecimen Announces Pricing of Initial Public OfferingiSpecimen Inc. ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the pricing of its initial public offering of 2,250,000 shares of its common stock at a price of $8.00 per share, for gross proceeds of $18,000,000 before deducting underwriting discounts, commissions and offering expenses. In addition, iSpecimen has granted the underwriters a 45-day option to purchase up to an additional 337,500 shares of common stock solely to cover over-allotment. |